Sign in
4

Changes in Ownership

Immunocore Holdings plc Filed Acc 0001955244-25-000005

HEAD OF R&D sold 22,732 shares at an average $35.66 ($810,701)

  • HEAD OF R&D acquired 22,732 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Berman David M · HEAD OF R&D

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-12 Exercise or conversion : show line 1 in the form 10b5-1 +22,532 $17.46 $393,409 22,532 D
2025-09-12 Sale : show line 2 in the form 10b5-1 −21,232 $35.63 $756,496 1,300 D
2025-09-12 Sale : show line 3 in the form 10b5-1 −1,300 $36.31 $47,203 0 D
2025-09-15 Exercise or conversion : show line 4 in the form 10b5-1 +200 $17.46 $3,492 200 D
2025-09-15 Sale : show line 5 in the form 10b5-1 −200 $35.01 $7,002 0 D
Open-market sales · 22,732 sh · avg $35.66 · $810,701

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-09-12 Exercise or conversion : show line 6 in the form 10b5-1 Employee Share Option (Right to Buy) −22,532 198,839 D
2025-09-15 Exercise or conversion : show line 7 in the form 10b5-1 Employee Share Option (Right to Buy) −200 198,639 D
Loading xslF345X05/form4-09162025_040906.xml…